https://www.ema.europa.eu/en/medicines/human/EPAR/nulibry 2022 false false false Netherlands French English treatment outcome syndication feed summary of product characteristics package leaflet drug evaluation orphan drug production fosdenopterin fosdenopterin nulibry Product containing only fosdenopterin in parenteral dose form (medicinal product form) drug approval europe molybdenum cofactor deficiency, complementation group A infusions, intravenous fosdenopterin product surveillance, postmarketing Fosdenopterin Hydrobromide pregnancy breast feeding Replacement Therapy drug evaluation, preclinical
ATC code(s)